Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$113.03 - $155.64 $1.14 Million - $1.57 Million
-10,100 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$99.52 - $215.83 $1.01 Million - $2.18 Million
10,100 New
10,100 $166,000
Q1 2019

May 10, 2019

SELL
$105.93 - $142.47 $16.1 Million - $21.7 Million
-152,200 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$128.36 - $272.13 $19.5 Million - $41.4 Million
152,200 New
152,200 $69,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.83B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.